What is NextGen Jane?
NextGen Jane is a pioneering biotechnology firm dedicated to the longitudinal molecular study of women's menstruation. By empowering menstruators to contribute their menstrual blood for genomic analysis, the company aims to unlock critical health data, providing early indicators for a range of health conditions and diseases. This innovative approach focuses on advancing the understanding of uterine biology, thereby enhancing women's health diagnostics and treatment options. The company's unique collection kit facilitates the secure submission of samples for detailed analysis, linking molecular findings to health outcomes.
How much funding has NextGen Jane raised?
NextGen Jane has raised a total of $11.3M across 2 funding rounds:
Angel/Seed
$2.3M
Series A
$9M
Angel/Seed (2019): $2.3M with participation from Undisclosed
Series A (2019): $9M led by Material Impact, Liminal Ventures, Access Industries, and Viking Global Investors
Key Investors in NextGen Jane
Material Impact
Material Impact is a venture capital firm focused on building deep tech companies that leverage material science for innovation, investing in first-of-their-kind technologies to create impactful solutions.
Access Industries
Access Industries is a privately-held industrial conglomerate making strategic global investments across media, natural resources, real estate, technology, entertainment, and biotechnology, focusing on long-term value creation.
Viking Global Investors
Viking Global Investors is a global investment firm specializing in research-intensive, long-term focused investments using fundamental analysis across public and private equity interests.
What's next for NextGen Jane?
The substantial enterprise-level funding positions NextGen Jane for significant scaling and further research and development. This capital infusion is expected to accelerate the company's efforts in expanding its molecular database, refining its analytical capabilities, and potentially forging strategic partnerships within the healthcare and biotechnology sectors. The focus on women's health diagnostics through novel molecular insights suggests a trajectory towards becoming a key player in personalized medicine and preventative care for obstetric and gynecological conditions.
See full NextGen Jane company page
